{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:37:49Z","timestamp":1771879069850,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00277-014-2087-z","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T07:53:06Z","timestamp":1398757986000},"page":"1587-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Allogeneic stem cell transplantation for mantle cell lymphoma\u2014final report from the prospective trials of the East German Study Group Haematology\/Oncology (OSHO)"],"prefix":"10.1007","volume":"93","author":[{"given":"William H.","family":"Kr\u00fcger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezda","family":"Basara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert G.","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Behre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Grobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gottfried","family":"D\u00f6lken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"issue":"3","key":"2087_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(00)00255-2","volume":"2","author":"I Barista","year":"2001","unstructured":"Barista I, Romaguera JE, Cabanillas F (2001) Mantle-cell lymphoma. Lancet Oncol 2(3):141\u2013148","journal-title":"Lancet Oncol"},{"issue":"11","key":"2087_CR2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","volume":"15","author":"M Bernard","year":"2001","unstructured":"Bernard M, Gressin R, Lefrere F, Drenou B, Branger B, Caulet-Maugendre S et al (2001) Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia 15(11):1785\u20131791","journal-title":"Leukemia"},{"key":"2087_CR3","doi-asserted-by":"crossref","unstructured":"Dreyling M, Kluin-Nelemans HC, Bea S, Hartmann E, Salaverria I, Hutter G et al (2011) Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: Report of the 10th Annual Conference of the European Mantle Cell Lymphoma Network. Leuk Lymphoma","DOI":"10.3109\/10428194.2011.600488"},{"issue":"9","key":"2087_CR4","first-page":"1437","volume":"7","author":"ME Williams","year":"1993","unstructured":"Williams ME, Swerdlow SH, Meeker TC (1993) Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 7(9):1437\u20131440","journal-title":"Leukemia"},{"issue":"7","key":"2087_CR5","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood.V83.7.1871.1871","volume":"83","author":"R Rimokh","year":"1994","unstructured":"Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD et al (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83(7):1871\u20131875","journal-title":"Blood"},{"issue":"2","key":"2087_CR6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/annonc\/mdh069","volume":"15","author":"J Mangel","year":"2004","unstructured":"Mangel J, Leitch HA, Connors JM, Buckstein R, Imrie K, Spaner D et al (2004) Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis. Ann Oncol 15(2):283\u2013290","journal-title":"Ann Oncol"},{"issue":"7","key":"2087_CR7","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","volume":"112","author":"CH Geisler","year":"2008","unstructured":"Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M et al (2008) Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 112(7):2687\u20132693","journal-title":"Blood"},{"issue":"2","key":"2087_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2002-08-2476","volume":"102","author":"AM Gianni","year":"2003","unstructured":"Gianni AM, Magni M, Martelli M, Di Nicola M, Carlo-Stella C, Pilotti S et al (2003) Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 102(2):749\u2013755","journal-title":"Blood"},{"issue":"6","key":"2087_CR9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","volume":"107","author":"C Pott","year":"2006","unstructured":"Pott C, Schrader C, Gesk S, Harder L, Tiemann M, Raff T et al (2006) Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood 107(6):2271\u20132278","journal-title":"Blood"},{"issue":"26","key":"2087_CR10","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2008.21.3116","volume":"27","author":"NS Andersen","year":"2009","unstructured":"Andersen NS, Pedersen LB, Laurell A, Elonen E, Kolstad A, Boesen AM et al (2009) Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. J Clin Oncol 27(26):4365\u20134370","journal-title":"J Clin Oncol"},{"issue":"1","key":"2087_CR11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.bmt.1701033","volume":"21","author":"N Kroger","year":"1998","unstructured":"Kroger N, Hoffknecht M, Dreger P, Kruger W, Zeller W, Krull A et al (1998) Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy. Bone Marrow Transplant 21(1):55\u201357","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2087_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V99.1.75","volume":"99","author":"P Corradini","year":"2002","unstructured":"Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F et al (2002) Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. Blood 99(1):75\u201382","journal-title":"Blood"},{"issue":"6","key":"2087_CR13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1702567","volume":"26","author":"C Martinez","year":"2000","unstructured":"Martinez C, Carreras E, Rovira M, Urbano-Ispizua A, Esteve J, Perales M et al (2000) Patients with mantle-cell lymphoma relapsing after autologous stem cell transplantation may be rescued by allogeneic transplantation. Bone Marrow Transplant 26(6):677\u2013679","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2087_CR14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1008380527502","volume":"10","author":"IF Khouri","year":"1999","unstructured":"Khouri IF, Lee MS, Romaguera J, Mirza N, Kantarjian H, Korbling M et al (1999) Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy. Ann Oncol 10(11):1293\u20131299","journal-title":"Ann Oncol"},{"issue":"1","key":"2087_CR15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.seminoncol.2003.10.017","volume":"31","author":"IF Khouri","year":"2004","unstructured":"Khouri IF, Champlin RE (2004) Nonmyeloablative stem cell transplantation for lymphoma. Semin Oncol 31(1):22\u201326","journal-title":"Semin Oncol"},{"issue":"2","key":"2087_CR16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558\u2013565","journal-title":"Blood"},{"issue":"10","key":"2087_CR17","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 6(10):1562\u20131568","journal-title":"J Clin Oncol"},{"issue":"3","key":"2087_CR18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2004-02-0738","volume":"104","author":"C Hirt","year":"2004","unstructured":"Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G (2004) Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 104(3):904\u2013905","journal-title":"Blood"},{"issue":"2","key":"2087_CR19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ijc.21346","volume":"118","author":"F Schuler","year":"2006","unstructured":"Schuler F, Dolken SC, Hirt C, Dolken MT, Mentel R, Gurtler LG et al (2006) No evidence for simian virus 40 DNA sequences in malignant non-Hodgkin lymphomas. Int J Cancer 118(2):498\u2013504","journal-title":"Int J Cancer"},{"issue":"4","key":"2087_CR20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbmt.2008.01.008","volume":"14","author":"P Armand","year":"2008","unstructured":"Armand P, Kim HT, Ho VT, Cutler CS, Koreth J, Antin JH et al (2008) Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. Biol Blood Marrow Transplant 14(4):418\u2013425","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2087_CR21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.bbmt.2010.04.006","volume":"16","author":"G Cook","year":"2010","unstructured":"Cook G, Smith GM, Kirkland K, Lee J, Pearce R, Thomson K et al (2010) Outcome following reduced-intensity allogeneic stem cell transplantation (RIC alloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 16(10):1419\u20131427","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2087_CR22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdi107","volume":"16","author":"AK Ganti","year":"2005","unstructured":"Ganti AK, Bierman PJ, Lynch JC, Bociek RG, Vose JM, Armitage JO (2005) Hematopoietic stem cell transplantation in mantle cell lymphoma. Ann Oncol 16(4):618\u2013624","journal-title":"Ann Oncol"},{"issue":"23","key":"2087_CR23","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1200\/JCO.2003.05.501","volume":"21","author":"IF Khouri","year":"2003","unstructured":"Khouri IF, Lee MS, Saliba RM, Jun G, Fayad L, Younes A et al (2003) Nonablative allogeneic stem-cell transplantation for advanced\/recurrent mantle-cell lymphoma. J Clin Oncol 21(23):4407\u20134412","journal-title":"J Clin Oncol"},{"issue":"12","key":"2087_CR24","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-06-2275","volume":"104","author":"MB Maris","year":"2004","unstructured":"Maris MB, Sandmaier BM, Storer BE, Chauncey T, Stuart MJ, Maziarz RT et al (2004) Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 104(12):3535\u20133542","journal-title":"Blood"},{"issue":"10","key":"2087_CR25","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/annonc\/mds054","volume":"23","author":"S Gouill Le","year":"2012","unstructured":"Le Gouill S, Kroger N, Dhedin N, Nagler A, Bouabdallah K, Yakoub-Agha I et al (2012) Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed\/refractory mantle cell lymphoma: a multicenter experience. Ann Oncol 23(10):2695\u20132703","journal-title":"Ann Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2087-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2087-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2087-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T14:07:20Z","timestamp":1597759640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2087-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2087"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2087-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}